Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Experimental Cell Research|April 23, 2011
Development of anti-CD20 therapy for multiple sclerosisBeatrix Bartok, Gregg J Silverman
Immunological Reviews|March 3, 2010
Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritisBeatrix Bartok, Gary S Firestein
Journal of Immunology (Baltimore, Md. : 1950)|January 29, 2014
Phosphoinositide 3-kinase δ regulates migration and invasion of synoviocytes in rheumatoid arthritisBeatrix Bartok, Deepa Hammaker, Gary S Firestein
The Journal of Pharmacology and Experimental Therapeutics|November 19, 2013
Novel phosphoinositide 3-kinase δ,γ inhibitor: potent anti-inflammatory effects and joint protection in models of rheumatoid arthritisDavid L Boyle, Hae-Rim Kim, Katharyn Topolewski, et al.
The Journal of Biological Chemistry|April 9, 2005
Post-transcriptional regulation of the yeast high affinity iron transport systemM Rosa Felice, Ivana De Domenico, Liangtao Li, et al.
Plos One|April 23, 2015
Integrative omics analysis of rheumatoid arthritis identifies non-obvious therapeutic targetsJohn W Whitaker, David L Boyle, Beatrix Bartok, et al.
The American Journal of Pathology|March 22, 2012
PI3 kinase δ is a key regulator of synoviocyte function in rheumatoid arthritisBeatrix Bartok, David L Boyle, Yi Liu, et al.
Rheumatology and Therapy|November 3, 2022
Benefit of Filgotinib, a JAK1 Preferential Inhibitor, in Rheumatoid Arthritis Patients with Previous Rapid Radiographic Progression: Post Hoc Analysis of Two TrialsYoshiya Tanaka, Tatsuya Atsumi, Daniel Aletaha, et al.
British Journal of Clinical Pharmacology|January 24, 2022
Exposure-response relationships for the efficacy and safety of filgotinib and its metabolite GS-829845 in subjects with rheumatoid arthritis based on phase 2 and phase 3 studiesAmy Meng, Kacey Anderson, Cara Nelson, et al.
Arthritis and Rheumatism|January 22, 2013
Protein tyrosine phosphatase expression profile of rheumatoid arthritis fibroblast-like synoviocytes: a novel role of SH2 domain-containing phosphatase 2 as a modulator of invasion and survivalStephanie M Stanford, Michael F Maestre, Amanda M Campbell, et al.
Pageof 3